Cary Street Partners Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
5,727
+291
+5% +$67.8K 0.29% 85
2026
Q1
$1.33M Buy
5,436
+792
+17% +$184K 0.34% 81
2025
Q4
$961K Buy
4,644
+528
+13% +$104K 0.26% 102
2025
Q3
$763K Buy
4,116
+698
+20% +$120K 0.32% 66
2025
Q2
$522K Buy
3,418
+174
+5% +$26.7K 0.25% 93
2025
Q1
$538K Buy
3,244
+932
+40% +$146K 0.31% 78
2024
Q4
$334K Sell
2,312
-115,938
-98% -$18M 0.22% 113
2024
Q3
$19.2M Sell
118,250
-2,467
-2% -$393K 0.71% 32
2024
Q2
$17.6M Buy
120,717
+2,074
+2% +$308K 0.71% 28
2024
Q1
$18.8M Buy
118,643
+4,149
+4% +$660K 0.79% 25
2023
Q4
$17.9M Buy
114,494
+1,381
+1% +$212K 0.85% 21
2023
Q3
$17.6M Buy
113,113
+28,921
+34% +$4.77M 0.95% 18
2023
Q2
$13.9M Buy
84,192
+740
+0.9% +$119K 0.9% 21
2023
Q1
$12.9M Sell
83,452
-2,396
-3% -$387K 0.93% 20
2022
Q4
$15.2M Buy
85,848
+7,217
+9% +$1.25M 1.12% 13
2022
Q3
$12.8M Buy
78,631
+9,590
+14% +$1.62M 1.06% 19
2022
Q2
$12.3M Buy
69,041
+49,167
+247% +$8.76M 1.04% 24
2022
Q1
$3.52M Sell
19,874
-1,345
-6% -$229K 0.97% 25
2021
Q4
$3.63M Buy
21,219
+3,025
+17% +$495K 1.01% 22
2021
Q3
$2.94M Sell
18,194
-582
-3% -$99.3K 0.96% 26
2021
Q2
$3.09M Buy
18,776
+7,728
+70% +$1.28M 1% 23
2021
Q1
$1.82M Sell
11,048
-46,859
-81% -$7.58M 0.75% 34
2020
Q4
$9.11M Sell
57,907
-7,371
-11% -$1.09M 1.76% 7
2020
Q3
$9.72M Buy
65,278
+62,061
+1,929% +$9.18M 2.06% 3
2020
Q2
$452K Buy
+3,217
New +$469K 0.64% 43
2020
Q1
Sell
-2,835
Closed -$414K 102
2019
Q4
$414K Buy
+2,835
New +$385K 0.45% 61
2018
Q4
$335K Buy
+2,600
New +$363K 0.33% 57

Other funds holding JNJ

Cary Street Partners Investment Advisory's JNJ Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Johnson & Johnson (JNJ) stake by 5.4% in Q2 2026, buying an estimated $67.8K and bringing the position to 5,727 shares worth $1.45M. The position accounts for 0.29% of the portfolio, ranked #85.

Cary Street Partners Investment Advisory first reported a position in JNJ in Q4 2018 and has held it in 27 quarters since. The position peaked at $19.2M in Q3 2024. 3,609 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cary Street Partners Investment Advisory held 5,727 shares of Johnson & Johnson worth $1.45M as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 291 Johnson & Johnson shares in Q2 2026, an estimated $67.8K.
  • Johnson & Johnson made up 0.29% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #85 holding.
  • Cary Street Partners Investment Advisory first reported a position in Johnson & Johnson in Q4 2018 and has held it in 27 quarters since.
  • Cary Street Partners Investment Advisory's Johnson & Johnson position peaked at $19.2M in Q3 2024.
  • 3,609 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.